CPHI Milan 2026

Projects

The pharmaceutical projects listed in this section are those that are announced from time to time around the world

Sanofi Invests US$470 million to Strengthen Vaccines Manufacturing Capacities

Sanofi plans to build a new vaccine production site in Singapore with an investment of US$470 million 400 million The new production site complements the current manufacturing facilities in Europe and North America

Astellas Pharma Plans to Construct New Manufacturing Lines for Aseptic Drug Products

Astellas Pharma Inc plans to construct new manufacturing linesfor aseptic drug products with an investment of US$16 million18 billion It will be located at Yaizu

Fujifilm Plans to Open Large Scale Cell Culture Production Site in USA

FUJIFILM Corporation plans to open a new large scale cell culture manufacturing site for biopharmaceuticals with an investment of more than

Taysha Plans New CGMP Gene Therapy Manufacturing Facility

Taysha Gene Therapies, Inc plans for the construction of new current Good Manufacturing Practices cGMP facility with an investment

Regis Expands Laboratory Facilities for API Pharmaceutical Development and Manufacturing

Regis Technologies, Inc plans to expand its laboratory facilities for the development of Active Pharmaceutical Ingredients APIs The facility will be located in Morton Grove, Illinois

DiNAQOR Opens New GMP Manufacturing Facility in Zurich

DiNAQOR plans to open its own GMP manufacturing facility which will be located at BioTechnopark SchlierenZrich

Rocket Pharmaceuticals Constructs New R & D Manufacturing Facility

Rocket Pharmaceuticals plans to construct a new R D and manufacturing facility in Cranbury, New Jersey

Fujifilm Invests US$40 million inNew State-of-the-Art Manufacturing Facility

FUJIFILM Corporation constructs new manufacturing facility for the development of viral vectors and advanced therapies with an investment of US$40 million The new stateoftheart manufacturing facility will be located at greaterBoston area

Thermo Fisher Constructs New cGMP Plasmid DNA Manufacturing Facility in California

Thermo Fisherplans to construct a new manufacturing facility for the production of clinical and commercial capabilities The facility will be located in Carlsbad, California The expansion of this facility enhances the commercialisation of plasmidbased medicines and vaccines

KBI Biopharma Invests $150 Millionto Expand Commercial Manufacturing Facility in North California

KBI Biopharma, Inc, plans to open a new facility for commercial manufacturing The manufacturing site involves an investment of US$150 million The facility will be located atResearch Triangle Park RTP in North Carolina